[ Price : $8.95]
FDA warns Koreas Outin Futures Corp. about CGMP and misbranding violations at its drug manufacturing facility.[ Price : $8.95]
Federal Register notice: FDA determines that Merck Sharp & Dohmes Noxafil (posaconazole) 100g delayed-release tablets were not wit...[ Price : $8.95]
Federal Register notice: FDA issues IntraBio a priority review voucher after determining its recent approval of Aqneursa (levacety...[ Price : $8.95]
FDA releases the form FDA-483 with 14 observations issued following an inspection at the Edmond, OK-based Qualgen outsourcing faci...[ Price : $8.95]
FDA clears an iCardio.ai 510(k) for its artificial intelligence software EchoMeasure for interpreting echocardiography.[ Price : $8.95]
Jazz Pharmaceuticals plans to file a supplemental NDA next year following positive top-line results from its Phase 3 clinical tria...[ Price : $8.95]
CDER director Patrizia Cavazzoni says the Center worked with CBER to launch in 2023 the START program, providing selected particip...[ Price : $8.95]
FDA posts a consumer-focused explanation of how CDER determines and manages drug shortages.